Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women

Human Pathology

Volumn 39, Issue 5, 2008, Pages 672-680

  Naqvi, Raza Ali ^a   Hussain, Arif ^a   Deo, Suryanarayan S V ^b   Kukreti, Himani ^c   Chauhan, Madhur ^a   Sarin, Ritu ^d   Saxena, Anubha ^a   Asim, Mohammad ^a   Shukla, Nootan Kumar ^b   Husain, Syed Akhtar ^a   Pasha, Syed Tazeen ^c   Basir, Seemi Farhat ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast cancer; hmlh1; hmlh2; Hypermethylation

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENOMIC INSTABILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; MICROSATELLITE INSTABILITY; NORTHERN BLOTTING; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CPG ISLANDS; DNA MISMATCH REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; LOSS OF HETEROZYGOSITY; METHYLATION; MICROSATELLITE INSTABILITY; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42649120661     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.09.011     Document Type: Article

References (44)

1. Goldhirsch A., Glick J.H., Gelber R.D., et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19 (2001) 3817-3827
2. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 352 (1998) 930-942
3. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 351 (1998) 1451-1467
4. Hayes D.F., Isaacs C., and Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6 (2001) 375-392
5. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
6. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 3 (2003) 253-266
7. Patel A., Groopman J.D., and Umar A. DNA Methylation as a cancer-specific biomarker. from molecules to populations. Ann NY Acad of Sci 983 (2003) 286-297
8. Costello J.C., Fruhwald M.C., Smiraglia D.J., et al. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat Genet 25 (2000) 132-138
9. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res 61 (2001) 3225-3229
10. Goessl K., Krause H., Muller M., et al. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60 (2000) 5941-5945
11. Eads C.A., Lord R.V., Wickramasinghe K., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61 (2001) 3410-3418
12. Lengauer C., Kinzler K.W., and Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 94 (1997) 2545-2550
13. Aaltonen L.A., Salovaara R., Kristo P., et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338 (1998) 1481-1487
14. Ichikawa Y., Tsunoda H., Takano K., Oki A., and Hiroyuki Y. Microsatellite instability and immunohistochemical analysis of hmlh1 and hmsh2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient. Japanese J Clin Oncol 32 (2002) 110-112
15. Aldaz C.M., Chen T., Sahin A., Cunningham J., and Bondy M. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55 (1995) 3976-3981
16. Contegiacomo A., Palmirotta R., De Marchis L., et al. Microsatellite instability and pathological aspects of breast cancer. Int J Cancer 64 (1995) 264-268
17. Cui J., Shen F., Jiang F., et al. Loss of heterozygosity and microsatellite instability in the region including BRCA1 of breast cancer in Chinese. Chung Hua I Hsueh I Chuan Hsueh Tsa Chih 15 (1998) 348-350
18. Fuji S., Takeshima Y., Arihiro K., et al. Microsatellite instability in breast cancers with special reference to patients' age and bilaterality. Hiroshima J Med Sci 47 (1998) 89-97
19. Jonsson M., Johannsson O., and Borg A. Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer. Eur J Cancer 31 (1995) 2330-2334
20. Paulson T.G., Wright F.A., Parker B.A., et al. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56 (1996) 4021-4026
21. Sobin L.H., and Fleming I.D. TNM Classification of malignant tumors. Cancer 80 (1997) 1803-1804
22. Devita Jr. V.T., Hellman S., and Rosenberg S.A. Cancer: principles and practice of oncology. 7th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 1435
23. Wang Y.C., Lu Y.P., Tseng R.C., et al. Inactivation of hmlh1 and hmsh2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 111 (2003) 887-895
24. Chialina S.G., Fornes C., Landi C., et al. Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue. BMC Med Genet 7 (2006) 5
25. Baylin S.B., and Herman J.G. DNA Hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16 (2000) 168-174
26. Herman J.G., and Baylin S.B. Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 249 (2000) 35-54
27. Rhyu M.S. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88 (1996) 240-251
28. Wang Y.C., Chen C.Y., Chen S.K., et al. High frequency of deletion mutation in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 58 (1998) 328-333
29. Modrich P., and Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Ann Rev Biochem 65 (1996) 101-133
30. Aaltonen L.A., Peltomaki P., Leach F.S., et al. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812-816
31. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
32. Peltomaki P., and de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 71 (1997) 93-119
33. Papadopoulos N., and Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mut 10 (1997) 89-99
34. Thibodeau S.N., French A.J., Roche P.C., et al. Altered expression of hmsh2 and hmlh1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56 (1996) 4836-4840
35. Borresen A.L., Lothe R.A., Meling G.I., et al. Somatic mutations in the hmsh2 gene in microsatellite unstable colorectal carcinomas. microsatellite unstable colorectal carcinomas. Hum Mol Genet 4 (1995) 2065-2072
36. Bubb V.J., Curtis L.J., and Cunningham C. Microsatellite instability and the role of hmsh2 in sporadic colorectal cancer. Oncogene 12 (1996) 2641-2649
37. Liu B., Nicolaides N.C., Markowitz S., et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9 (1995) 48-55
38. Herman J.G., Umar A., Polyak K., et al. Incidence and functional consequences of hmlh1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95 (1998) 6870-6875
39. Salvesen H.B., MacDonald N., Ryan A., et al. Methylation of hmlh1 in a population-based series of endometrial carcinomas. Clin Cancer Res 6 (2000) 3607-3613
40. Cunningham J.M., Christensen E.R., Tester D.J., et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hmlh1. Cancer Res 58 (1998) 3455-3460
41. Esteller M., Levine R., Baylin S.B., et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 17 (1998) 2413-2417
42. Strathdee G., MacKean M.J., Illand M., and Brown R. A role for methylation of the hmlh1 promoter in loss of hmlh1 expression and drug resistance in ovarian cancer. Oncogene 18 (1999) 2335-2341
43. Mackay H.J., Cameron D., Rahilly M., et al. Reduced mlh1 expression in breast tumors after primary chemotherapy predicts disease-free survival. J Clin Oncol 18 (2000) 87-93
44. Harima Y., Harima K., Sawada S., et al. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer. Clin Can Res 6 (2000) 1079-1085